MilliporeSigma Brochures
-
Amplified Innovation, Amplified Impact
4/1/2026
Discover ultra pure enzymes, reagents, and isolation kits that are designed to reduce contamination risk and support reliable molecular diagnostics workflows, from sample prep through amplification.
-
Small Volume Custom Media
4/1/2026
Support early-stage bioprocess development with expedited access to small-volume custom media and buffers, backed by GMP-aligned quality systems, formulation expertise, and global consistency.
-
BioRepository Services
3/20/2026
Reliable sample protection comes from secure facilities. Learn how multiple storage formats, split‑site options, and full audit trails help ensure biological materials remain ready for future use.
-
Empower Your Studies With Our Expertise
3/18/2026
Look at how optimized virus banking strengthens manufacturing by enhancing consistency, speeding characterization timelines, and aligning testing strategies with modern regulatory expectations.
-
Starting Point Of Every Success Story
3/18/2026
Reliable cell banks are essential for protecting research quality. See how expert support and structured processes help maintain cell line integrity, reduce risk, and strengthen development.
-
Ensure Complete Characterization Of Your Rodent Cell Line
3/13/2026
Targeted NGS brings fast detection of rodent viruses to cell line characterization. Discover an automated workflow that supports reliable identification and helps teams strengthen contamination control.
-
High‑Purity Nucleoside Triphosphates
3/13/2026
High‑purity nucleoside triphosphates are essential for reliable mRNA production. Learn more about their quality specifications, consistency, and regulatory support for production workflows.
-
Chemicals For mRNA Drug Manufacturing
3/13/2026
Get a clear overview of high-quality chemicals and lipids that support each step of pDNA and mRNA manufacturing, helping streamline processes, strengthen consistency, and enable reliable LNP formulation.
-
Gene Therapy Capabilities For AAV And Lentivirus Production Platforms
3/9/2026
Get a clear look at the sequential steps behind robust AAV and lentiviral manufacturing, highlighting key process decisions and practical considerations for building reliable gene therapy workflows.
-
NGS AAT For Cell Line Characterization
2/24/2026
A modern sequencing‑based assay strengthens cell line characterization with greater sensitivity. See how it supports confident, objective safety decisions and helps reduce risk during early development.